Fluvastatin alters psychomotor performance and daily activity but not the spatial memory in rats

Tohoku Journal of Experimental Medicine

Volumn 209, Issue 4, 2006, Pages 311-320

  Baytan, Sukrucan H ^a,b   Alkanat, Mehmet ^a   Ozeren, Mehmet ^a   Ekinci, Murat ^a   Akgun, Ahmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Barnes maze; Behavior; Fluvastatin; Psychomotor; Statin

Indexed keywords

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ANALYTICAL ERROR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LATENT PERIOD; LIPID BRAIN LEVEL; LIPID COMPOSITION; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; MOBILIZATION; NONHUMAN; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; ROTAROD TEST; SPATIAL MEMORY; STATISTICAL ANALYSIS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BEHAVIOR, ANIMAL; FATTY ACIDS, MONOUNSATURATED; FEMALE; INDOLES; MALE; MEMORY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746632472     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.209.311     Document Type: Article

References (43)

1. Baker, S.K. (2005) Molecular clues into the pathogenesis of statin-mediated muscle toxicity. Muscle Nerve, 31, 572-580.
2. Barnes, C.A. (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol., 93, 74-104.
3. Bjorkhem, I. & Meaney, S. (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol., 24, 806-815.
4. Boesel, J., Gandor, F., Harms, C., Synowitz, M., Harms, U., Djoufack, P.C., Megow, D., Dirnagl, U., Hortnagl, H., Fink, K.B. & Endres, M. (2005) Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J. Neurochem., 92, 1386-1398.
5. Collins, R., Armitage, J., Parish, S., Sleight, P. & Peto, R. (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet, 363, 757-767.
6. De Angelis, G. (2004) The influence of statin characteristics on their safety and tolerability. Int. J. Clin. Pract., 58, 945-955.
7. Depue, R.A. & Iacono, W.G. (1989) Neurobehavioral aspects of affective disorders. Annu. Rev. Psychol., 40, 457-492.
8. Dietschy, J.M. & Turley, S.D. (2004) Thematic Review Series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res., 45, 1375-1397.
9. Fowles, D.C. (1988) Psychophysiology and psychopathology: A motivational approach. Psychophysiology, 25, 373-391.
10. Gengo, F., Cwudzinski, D., Kinkel, P., Block, G., Stauffer, L. & Lines, C. (1995) Effects of treatment with lovastatin and pravastatin on daytime cognitive performance. Clin. Cardiol., 18, 209-214.
11. Gimenez-Llort, L., Wang, F., Ogren, S.O. & Ferre, S. (2002) Local dopaminergic modulation of the motor activity induced by N-methyl-D-aspartate receptor stimulation in the ventral hippocampus. Neuropsychopharmacology, 26, 737-743.
12. Golomb, B.A., Kane, T. & Dimsdale, J.E. (2004a) Severe irritability associated with statin cholesterol-lowering drugs. QJM, 97, 229-235.
13. Golomb, B.A., Criqui, M.H., White, H.L. & Dimsdale, J.E. (2004b) The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes. Control. Clin. Trials., 25, 178-202.
14. Gray, J.A. (1990) Brain systems that mediate both emotion and cognition. Cognition and Emotion, 4, 269-288.
15. Gray, J.A. (1991) Neural systems, emotion, and personality. In: Neurobiology of Learning, Emotion, and Affect, edited by J. Madden, Raven Press, NewYork, pp. 273-306.
16. Gray, J.A. (1994) Framework for a taxonomy of psychiatric disorder. In: Emotions: Essays on Emotion Theory, edited by S.H.M. van Goozen, N.E. van de Poll & J. Sergeant, Hillsdale Erlbaum, New Jersey, pp. 29-59.
17. Guillot, F., Misslin, P. & Lemaire, M. (1993) Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. J. Cardiovasc. Pharmacol., 21, 339-346.
18. Johnson-Anuna, L.N., Eckert, G.P., Keller, J.H., Igbavboa, U., Franke, C., Fechner, T., Schubert-Zsilavecz, M., Karas, M., Muller, W.E. & Wood, W.G. (2005) Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J. Pharmacol. Exp. Ther., 312, 786-793.
19. Kato, T., Hashikabe, H., Iwata, C., Akimoto, K. & Hattori, Y. (2004) Statin blocks Rho/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cells. Biochim. Biophys. Acta, 1689, 267-272.
20. King, D.S., Wilburn, A.J., Wofford, M.R., Harrell, T.K., Lindley, B.J. & Jones, D.W. (2003) Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy, 23, 1663-1667.
21. Kirsch, C., Eckert, G.P. & Mueller, W.E. (2003) Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem. Pharmacol., 65, 843-856.
22. Lee, R.S., Koob, G.F. & Henriksen, S.J. (1998) Electrophysiological responses of nucleus accumbens neurons to novelty stimuli and exploratory behavior in the awake, unrestrained rat. Brain Res., 20, 317-322.
23. Liao, J.K. (2002) Lipid lowering: the role of statins in vascular protection. Int. J. Cardiol., 86, 5-18.
24. Liao, J.K. (2004) Statins: potent vascular anti-inflammatory agents. Int. J. Clin. Pract. Suppl., 143, 41-48.
25. Liao, J.K. (2005) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am. J. Cardiol., 96, 24F-33F.
26. Lu, D., Mahmood, A., Goussev, A., Schallert, T., Qu, C., Zhang, Z.G., Li, Y., Lu, M. & Chopp, M. (2004) Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J. Neurosurg., 101, 813-821.
27. Maron, D.J., Fazio, S. & Linton, M.F. (2000) Current perspectives on statins. Circulation, 101, 207-213.
28. Mauch, D.H., Nagler, K., Schumacher, S., Goritz, C., Muller, E.C., Otto, A. & Pfrieger, F.W. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294, 1354-1357.
29. Muldoon, M.F., Barger, S.D., Ryan, C.M., Flory, J.D., Lehoczky, J.P., Matthews, K.A. & Manuck, S.B. (2000) Effects of lovastatin on cognitive function and psychological well-being. Am. J. Med., 108, 538-546.
30. Muldoon, M.F., Ryan, C.M., Sereika, S.M., Flory, J.D. & Manuck, S.B. (2004) Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am. J. Med., 117, 823-829.
31. Norton, W.T. & Cammer, W. (1984) Isolation and characterization of myelin. In: Myelin, edited by P. Morell, Vol. 2, Plenum Press, New York, pp. 147-180.
32. Obata, T. & Yamanaka, Y. (2000) Protective effect of fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on MPP(+)-induced hydroxyl radical in the rat striatum. Brain Res., 860, 166-169.
33. Parale, G.P., Bahetti N.N., Kulkarni, P.M. & Panchhal, N.V. (2006) Effects of atorvastatin on higher functions. Eur. J. Clin. Pharmacol., 27, 425-446.
34. Sacher, J., Weigl, L., Werner, M., Szegedi, C. & Hohenegger, M. (2005) Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J. Pharmacol. Exp. Ther., 314, 1032-1041.
35. Saul'skaia, N.B. & Gorbachevskaia, A.I. (1998) Participation of the hippocampus in regulation of GABA release in the nucleus accumbens during emotional conditioning. Ross Fiziol. Zh. Im. I. M. Sechenova., 84, 43-49.
36. Schaefer, E.J., McNamara, J.R., Tayler, T., Daly, J.A., Gleason, J.L., Seman, L.J., Ferrari, A. & Rubenstein, J.J. (2004) Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatim, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Am. J. Cardiol., 93, 31-39.
37. Schulz, J.G., Bosel, J., Stoeckel, M., Megow, D., Dirnagl, U. & Endres, M. (2004) HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophospha te synthesis. J. Neurochem., 89, 24-32.
38. Snipes, G.J. & Suter, U. (1997) Cholesterol and Myelin. In: Subcellular Biochemistry, edited by R. Bittman, Vol. 28, Plenum Press, New York, pp. 173-204.
39. Steiniger-Brach, B. & Kretschmer, B.D. (2005) Different function of pedunculopontine GABA and glutamate receptors in nucleus accumbens dopamine, pedunculopontine glutamate and operant discriminative behavior. Eur. J. Neurosci., 22, 1720-1730.
40. Turner, R.J., Van den Heuvel, C. & Vink, R. (2004) Amiloride increases neuronal damage after traumatic brain injury in rats. J. Am. Coll. Nutr., 23, 534S-537S.
41. Vecka, M., Tvrzicka, E., Stankova, B., Novak, F., Novakova, O. & Zak, A. (2004) Hypolipidemic drugs can change the composition of rat brain lipids. Tohoku J. Exp. Med., 204, 299-308.
42. Wagstaff, L.R., Mitton, M.W., Arvik, B.M. & Doraiswamy, P.M. (2003) Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy, 23, 871-880.
43. Wang, Q., Ting, W.L., Yang, H. & Wong, P.T. (2005) High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase. Br. J. Pharmacol., 144, 933-939.